(Q58823409)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Efficacy and safety of fluvastatin, a new HMG CoA reductase inhibitor, in elderly hypercholesterolaemic women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

G Baggio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

O De Candia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

P L Forte

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

F Mello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Andriolli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

S Donazzan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

G Valerio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

G Crepaldi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

language of work or name

English

0 references

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

47 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

59-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7517835%20AND%20SRC:MED&resulttype=core&format=json

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

20 October 2019

cites work

1 reference

12 December 2020

Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.

1 reference

12 December 2020

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

1 reference

12 December 2020

A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.

1 reference

12 December 2020

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

1 reference

12 December 2020

Should the elderly be screened for hypercholesterolemia?

1 reference

12 December 2020

HMG-CoA reductase inhibitor use in the aged. A review of clinical experience

1 reference

12 December 2020

Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers

1 reference

12 December 2020

The epidemiology of cardiovascular disease in older persons

1 reference

12 December 2020

Cardiovascular health and disease in women

1 reference

12 December 2020

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholester

1 reference

12 December 2020

Comparison of death rates from acute myocardial infarction in a single hospital in two different periods (1977-1978 versus 1988-1989)

1 reference

12 December 2020

Treatment of hypercholesterolemia in the elderly

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

Hypercholesterolemia in elderly persons: resolving the treatment dilemma

1 reference

12 December 2020

Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study

1 reference

12 December 2020

Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol.

1 reference

12 December 2020

High blood cholesterol in elderly men and the excess risk for coronary heart disease

1 reference

12 December 2020

The epidemiology of cardiovascular disease in postmenopausal women

1 reference

12 December 2020

HMG-CoA reductase inhibitors: an exciting development in the treatment of hyperlipoproteinemia

1 reference

12 December 2020

Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study). The European Study Group

1 reference

12 December 2020